Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited10.907414194524.4103
Domestic EquitiesDivi's Laboratories Limited8.90373117119.9261
Domestic EquitiesApollo Hospitals Enterprise Limited5.91101878413.2286
Domestic EquitiesMax Healthcare Institute Limited5.637512072112.6166
Domestic EquitiesTorrent Pharmaceuticals Limited4.54952644610.1817
Domestic EquitiesAurobindo Pharma Limited3.9970756148.9451
Domestic EquitiesFortis Healthcare Limited3.5757905248.0023
Domestic EquitiesCohance Lifesciences Limited3.45491462717.7319
Domestic EquitiesLupin Limited3.3980360507.6047
Domestic EquitiesAlkem Laboratories Limited3.0640124536.8572
Domestic EquitiesAster DM Healthcare Limited2.95301071346.6086
Domestic EquitiesNeuland Laboratories Limited2.793741206.2521
Domestic EquitiesWockhardt Limited2.5096388355.6163
Domestic EquitiesAbbott India Limited2.398018495.3667
Domestic EquitiesLaurus Labs Limited2.0482413694.5837
Domestic EquitiesCipla Limited1.9443287924.3513
Domestic EquitiesGlenmark Pharmaceuticals Limited1.9367212964.3342
Domestic EquitiesDr. Reddy's Laboratories Limited1.7915315344.0092
Domestic EquitiesMankind Pharma Limited1.7221175463.8540
Domestic EquitiesSai Life Sciences Limited1.6072395953.5968
Domestic EquitiesFDC Limited1.4402761793.2231
Domestic EquitiesIPCA Laboratories Limited1.4258224883.1908
Domestic EquitiesHealthcare Global Enterprises Limited1.3987472853.1303
Domestic EquitiesSumitomo Chemical India Limited1.3634647813.0512
Domestic EquitiesSBI Life Insurance Company Limited1.3485148303.0178
Domestic EquitiesBiocon Limited1.3325757062.9821
Domestic EquitiesOrchid Pharma Limited1.2296362582.7518
Domestic EquitiesOnesource Specialty Pharma Limited1.2127149892.7139
Domestic EquitiesPiramal Pharma Limited1.20561566752.6981
Domestic EquitiesRainbow Childrens Medicare Limited1.1885201502.6598
Domestic EquitiesPark Medi World Limited1.17241790322.6237
Domestic EquitiesLinde India Limited1.091841032.4435
Domestic EquitiesStandard Glass Lining Technology Ltd1.04341553672.3350
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.018392132.2789
Domestic EquitiesPoly Medicure Limited0.9545120442.1362
Domestic EquitiesCaplin Point Laboratories Limited0.8582104491.9206
Domestic EquitiesSupriya Lifescience Limited0.8519253701.9066
Domestic EquitiesAstraZeneca Pharma India Limited0.758518801.6975
Domestic EquitiesShilpa Medicare Limited0.7113495681.5919
Domestic EquitiesZydus Lifesciences Limited0.6861167921.5354
Domestic EquitiesSyngene International Limited0.4992171591.1171
Total 97.8938 219.0827
Cash & Cash Equivalents and Net AssetsTREPS 01-Jan-20262.4129 5.4000
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.3067 -0.6864
Total 2.1062 4.7136
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.